Trade Symposia
Open to all registered delegates
Friday 27 November 2026
Gilead Symposium
- 07:00 - 08:00
- Theme: Blood-Borne Viruses Through the Blood-Brain Barrier
- How Hepatitis C Virus (HCV) Shapes Brain Health, Behaviour and Neuropsychiatric Outcomes

Prof Mark Sonderup
View Bio
Prof Mark Sonderup is a hepatologist, Professor of Medicine and Head of the Division of Hepatology and the Liver and Liver Transplant Clinic at Groote Schuur Hospital and the University of Cape Town, South Africa. He is a recognised authority in liver disease, with particular expertise in viral hepatitis and liver transplantation, and has published extensively in peer-reviewed medical journals. His academic and clinical work has contributed to advancing the understanding and management of viral hepatitis in South Africa and internationally. Prof. Sonderup is also an author of the chapter on hepatitis C, including its extra-hepatic manifestations, in the 14th edition of Sherlock’s Diseases of the Liver and Biliary System, a leading international reference in hepatology. At the Biological Psychiatry Conference, Prof. Sonderup brings a hepatologist’s perspective to an important multidisciplinary conversation: HCV is not solely a disease of the liver. Its extra-hepatic manifestations, including those relevant to neuropsychiatric health, reinforce the importance of recognising HCV risk, screening appropriately and connecting patients to curative treatment.
Adcock Ingram Symposium
- 18:15 - 19:30
- Theory to Innovative Therapeutic in Bipolar Disorder: Cariprazine Efficacy Across the spectrum of bipolar disorder

Prof Roger McIntyre
View Bio
Dr. Roger McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto. Dr. McIntyre was named by Clarivate Analytics in for a decade as one of “The World’s Most Influential Scientific Minds”. This distinction is given by publishing the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade. Dr. McIntyre has authored/co-authored more than 1200 articles/manuscripts and has edited and/or co-edited several textbooks on mood disorders. Dr. McIntyre is involved in multiple research endeavours which primarily aim to characterize the phenomenology, neurobiology, and novel therapeutics of mood disorders. Dr. McIntyre has been especially interested in identifying innovative, rapid acting psychotropic treatments for mood disorders. Dr. McIntyre’s research has also extended into public health and implementation research at the population-based level. Dr. McIntyre is extensively involved in medical education. He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto, Department of Psychiatry and has been a recipient of the joint Canadian Psychiatric Association (CPA) / Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada. Additionally, Dr. McIntyre was awarded the Colvin Prize for Outstanding Achievement in Mood Disorders Research from the Brain and Behavior Research Foundation in 2023. Dr. McIntyre has also contributed extensively to clinical practice guidelines. For example, Dr. McIntyre is the lead author the Florida Best Practice Psychotherapeutic Medication Guidelines for Adults with Major Depressive Disorder and Bipolar Disorder. In addition, Dr. McIntyre is also the lead author of the International Expert Opinion on the Available Evidence and Implementation of Ketamine and Esketamine in Mood Disorders. Dr. McIntyre is also a contributor to the CANMAT guidelines for the treatment of Depressive Disorders and Bipolar Disorders as well as the Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for Mood Disorders. Dr. McIntyre completed his medical degree at Dalhousie University. He received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.
Saturday 28 November 2026
Cipla Symposium
- 07:15 - 08:15
- Interrupting the Path to Suicide

Dr Frans Korb
View Bio
Dr Frans August Korb is a specialist psychiatrist and received the following university qualifications: B.Sc. (Hons) (UFS), M.A. Clinical Psychology (Wits), M.B. Ch.B. (UCT), M.Med. Psychiatry (Wits). He has a particular interest in adult mood and anxiety disorders, as well as adult ADHD. He is currently in full-time private practice in Sandton and also consults for Life Healthcare Nkanyisa at both Baneng Care Centre and Waverley Care Centre. Since 2007, Dr Korb has been an invited annual lecturer in psychopharmacology at the Department of Psychology at the University of Johannesburg. He served as an examiner for the CMSA FCPsych Part I examinations from 2002 to 2021. Dr Korb has been actively involved with the South African Depression and Anxiety Group (SADAG) since its inception in 1994, serving on the board and previously as board chairman. He has extensive experience in clinical research, having participated in numerous clinical trials for various pharmaceutical companies. His industry experience includes roles as a medical advisor for CNS and anti-inflammatories at Pfizer Laboratories (1999–2000) and Eli Lilly and Company (2000–2009). He also served as a global medical advisor based at the Lilly Area Medical Centre in Vienna and School of Clinical Research, Austria. Over the years, Dr Korb has contributed to several professional organizations, including the Associated Scientific and Technical Societies of South Africa (AS&TS), the Southern African Association for the Advancement of Science (S2A3), the South African Society of Psychiatrists (SASOP), Founder Member of PsychMG, and the South African Medical Association (SAMA). He currently serves as editor of Mental Health Matters, a journal for general practitioners, and sits on the editorial board of Neuron SA. He has published widely in peer-reviewed journals and the mainstream press and is a regular contributor to radio and television discussions on mental health topics. In recognition of his contributions, Dr Korb was awarded Certificates of Merit by the Southern African Association for the Advancement of Science in 1989 and 1992.